LIGAND PHARMACEUTICALS INC — Director's Dealing 2014

Jun 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2014-06-04

Reporting Person: LAMATTINA JOHN L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-04	Common Stock	A	1151.0	$0.0	Acquired	22507	Direct
2014-06-04	Common Stock	A	333.0	$0.0	Acquired	22840	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-04	Non-Qualified Stock Option (right to buy)	$67.53	A	3312.0	Acquired	2024-06-04	Common Stock (3312)	Direct

Footnotes

F1: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2014. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

F2: Immediately vested restricted shares issued in lieu of annual cash retainer

F3: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2014. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.